TY - JOUR
T1 - A kidney-specific fasting-mimicking diet induces podocyte reprogramming and restores renal function in glomerulopathy
AU - Villani, Valentina
AU - Frank, Camille Nicolas
AU - Cravedi, Paolo
AU - Hou, Xiaogang
AU - Bin, Sofia
AU - Kamitakahara, Anna
AU - Barbati, Cristiani
AU - Buono, Roberta
AU - Da Sacco, Stefano
AU - Lemley, Kevin V.
AU - De Filippo, Roger E.
AU - Lai, Silvia
AU - Laviano, Alessandro
AU - Longo, Valter D.
AU - Perin, Laura
PY - 2024/10/30
Y1 - 2024/10/30
N2 - Cycles of a fasting-mimicking diet (FMD) promote regeneration and reduce damage in the pancreases, blood, guts, and nervous systems of mice, but their effect on kidney disease is unknown. In addition, a FMD has not been tested in rats. Here, we show that cycles of a newly developed low-salt FMD (LS-FMD) restored normal proteinuria and nephron structure and function in rats with puromycin-induced nephrosis compared with that in animals with renal damage that did not receive the dietary intervention. LS-FMD induced modulation of a nephrogenic gene program, resembling renal developmental processes in multiple kidney structures. LS-FMD also activated podocyte-lineage reprogramming pathways and promoted a quiescent state in mature podocytes in the rat kidney damage model. In a pilot clinical study in patients with chronic kidney disease, FMD cycles of 5 days each month for 3 months promoted renoprotection, including reduction of proteinuria and improved endothelial function, compared with that in patients who did not receive the FMD cycles. These results show that FMD cycles, which promote the reprogramming of multiple renal cell types and lead to glomerular damage reversal in rats, should be tested further for the treatment of progressive kidney diseases.
AB - Cycles of a fasting-mimicking diet (FMD) promote regeneration and reduce damage in the pancreases, blood, guts, and nervous systems of mice, but their effect on kidney disease is unknown. In addition, a FMD has not been tested in rats. Here, we show that cycles of a newly developed low-salt FMD (LS-FMD) restored normal proteinuria and nephron structure and function in rats with puromycin-induced nephrosis compared with that in animals with renal damage that did not receive the dietary intervention. LS-FMD induced modulation of a nephrogenic gene program, resembling renal developmental processes in multiple kidney structures. LS-FMD also activated podocyte-lineage reprogramming pathways and promoted a quiescent state in mature podocytes in the rat kidney damage model. In a pilot clinical study in patients with chronic kidney disease, FMD cycles of 5 days each month for 3 months promoted renoprotection, including reduction of proteinuria and improved endothelial function, compared with that in patients who did not receive the FMD cycles. These results show that FMD cycles, which promote the reprogramming of multiple renal cell types and lead to glomerular damage reversal in rats, should be tested further for the treatment of progressive kidney diseases.
UR - http://www.scopus.com/inward/record.url?scp=85208167205&partnerID=8YFLogxK
U2 - 10.1126/scitranslmed.adl5514
DO - 10.1126/scitranslmed.adl5514
M3 - Article
C2 - 39475573
AN - SCOPUS:85208167205
SN - 1946-6234
VL - 16
SP - eadl5514
JO - Science Translational Medicine
JF - Science Translational Medicine
IS - 771
ER -